VANCOUVER (GenomeWeb News) – Research commercialization, intellectual property, data release, and open access may not be mutually exclusive goals in bringing genomic discoveries to market, according to some experts.
 
Researchers grappled with these and other big questions — including public perceptions of research — at the opening session of a Genome Canada conference called “2020 Vision: The Impact of Science in Society” in Vancouver yesterday.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.